Trypsin inhibitor in acute hepatitis: Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 2, 2002, Pages 140-147

  Lin, Shi De ^a,b   Sato, Akihiro ^b   Takikawa, Yasuhiro ^b   Shirakawa, Kamon ^c   Suzuki, Kazuyuki ^b  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Acute hepatitis; Fulminant hepatitis; Urinary trypsin inhibitor

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; FIBRINOGEN; PLASMINOGEN; ULINASTATIN; GLYCOPROTEIN; TRYPSIN INHIBITOR;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SIMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HUMAN; LIVER DYSFUNCTION; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTHROMBIN TIME; ACUTE DISEASE; HEPATIC ENCEPHALOPATHY; HEPATITIS; LIVER FAILURE; LIVER FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ACUTE DISEASE; ADULT; AGED; FEMALE; GLYCOPROTEINS; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; LIVER FAILURE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; TRYPSIN INHIBITORS;

EID: 0036482581     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02676.x     Document Type: Article

References (33)

1. The inter-α-inhibitor family: From structure to regulation
2. Biosynthesis of bikunin (urinary trypsin inhibitor) in rat hepatocytes
3. Urinary trypsin inhibitor: Production in the liver and reabsorption in the kidney of the rats
4. High glomerular permeability of bikunin despite similarity in charge and hydrodynamic size to serum albumin
5. Down-regulation of interleukin-8 gene expression in HL 60 cell line by human Kunitz-type trypsin inhibitor
6. 2+ influx
7. The effect of Ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastase
8. Urinary trypsin inhibitor in man ('Mingin')
9. Inter-α-trypsin inhibitor (ITI): Use of new antisera for qualitative studies and discrete quantitation of ITI and its derivatives
10. Human inter-α-inhibitor family in inflammation: Simultaneous synthesis of positive and negative acute-phase protein
11. Trypsin-inhibitory activities of acid-stable fragments of the inter-alpha-trypsin inhibitor in inflammatory and uraemic conditions
12. The management of fulminant hepatic failure
13. Essential roles of the Fas ligand in the development of hepatitis
14. Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis: Relationship with soluble Fas, tumor necrosis factorα and TNF receptor-1
15. Relationship between plasma polymorphonuclear leukocyte elastase and coagulatory-fibrinolytic activities in acute hapatic failure
16. Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio?
17. Aetiology and prognosis of fulminant viral hepatitis in Japan: A multicentre study
18. Usefulness of antithrombin III and α2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis
19. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine
20. Distribution and localization of inter-α-tripsin inhibitor and its active component acid-stable proteinase inhibitor: Comparative immunohistochemical study
21. Inter-alpha-trypsin inhibitor-related immunoreactivity in human tissues and body fluids
22. Developmentally regulated transcription of the four liver-specific genes for inter-α-inhibitor family in mouse
23. Bikunin in rat plasma, lymph and bile
24. Immunohistochemical demonstration of inter-α-tripsin inhibitor light chain (bikunin) in human mast cells
25. Serum levels of a component reacting with antiserum to urinary anti-trypsin in health and disease with emphasis on high levels in renal failure
26. Uptake of human urinary trypsin inhibitor by the kidney epithelial cell line, LLC-PK1
27. Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor
28. Characterization of the cellular binding site for the urinary trypsin inhibitor
29. Urinary secretion of Ulinastatin and the effect of Milaclid® to the renal function in cirrhotic patients during the postoperative period
30. Role of O-linked carbohydrate of human urinary trypsin inhibitor on its lysosomal membrane-stabilizing property
31. Effect of Ulinastatin on the elastase release in multiple injuries
32. Protective effect of Ulinastatin against liver injury caused by ischemia-reperfusion in rats
33. Protective effects of Ulinastatin against ischemia-reperfusion injury